Acute hypocalcaemia following denosumab in heart and lung transplant recipients with osteoporosis
Internal Medicine Journal Jan 29, 2018
Shrosbree JE, et al. - Researchers resolved to inspect the risk of hypocalcaemia in a heart and lung transplant cohort who had received denosumab for osteoporosis. Based on the results, findings recommended judicious use of denosumab in patients with advanced renal disease due to the risk of hypocalcaemia.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
